Cargando…

CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings

BACKGROUND: Studies have demonstrated increased risk of major atherothrombotic events in CYP2C19 loss‐of‐function (LOF) variant carriers versus non‐carriers treated with clopidogrel after percutaneous coronary intervention (PCI). We sought to evaluate real‐world outcomes with the clinical implementa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beitelshees, Amber L., Thomas, Cameron D., Empey, Philip E., Stouffer, George A., Angiolillo, Dominick J., Franchi, Francesco, Tuteja, Sony, Limdi, Nita A., Lee, James C., Duarte, Julio D., Kreutz, Rolf P., Skaar, Todd C., Coons, James C., Giri, Jay, McDonough, Caitrin W., Rowland, Rachel, Stevenson, James M., Thai, Thuy, Vesely, Mark R., Wellen, Jacob T., Johnson, Julie A., Winterstein, Almut G., Cavallari, Larisa H., Lee, Craig R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245803/ https://www.ncbi.nlm.nih.gov/pubmed/35156424 http://dx.doi.org/10.1161/JAHA.121.024159

Ejemplares similares

Evaluating the Extent of Reusability of CYP2C19 Genotype Data among Patients Genotyped for Antiplatelet Therapy Selection
por: Beitelshees, Amber L., et al.
Publicado: (2020)

Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
por: Coons, James C, et al.
Publicado: (2023)

Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions
por: Angiolillo, Dominick J.
Publicado: (2009)

De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?
por: Galli, Mattia, et al.
Publicado: (2022)

The Role of Antiplatelet Therapy in Patients With MINOCA
por: Ortega-Paz, Luis, et al.
Publicado: (2022)

Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network
por: Duong, Benjamin Q, et al.
Publicado: (2020)

Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention
por: El Rouby, Nihal, et al.
Publicado: (2020)

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing
por: Cavallari, Larisa H., et al.
Publicado: (2019)

Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients
por: Ramsey, Laura B., et al.
Publicado: (2020)

Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use
por: Capodanno, Davide, et al.
Publicado: (2019)

Assessing the Clinical Treatment Dynamics of Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention in the US
por: Wang, Yehua, et al.
Publicado: (2023)

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
por: Beitelshees, Amber L, et al.
Publicado: (2015)

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
por: Cavallari, Larisa H., et al.
Publicado: (2018)

Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations
por: Cho, Sung Won, et al.
Publicado: (2019)

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
por: Tuteja, Sony, et al.
Publicado: (2021)

Best–worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy
por: Salloum, Ramzi G., et al.
Publicado: (2022)

The Horse’s Foot
por: McDonough, James T.
Publicado: (1902)

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting
por: Cavallari, LH, et al.
Publicado: (2017)

MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation
por: Guarino, Maria Luisa, et al.
Publicado: (2020)

Object-oriented design with ABAP: a practical approach
por: McDonough, James E
Publicado: (2017)

2246: Characterization of resistant hypertension in a statewide electronic health record-based database (OneFlorida)
por: McDonough, Caitrin W., et al.
Publicado: (2018)

Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial
por: Li, Yi, et al.
Publicado: (2020)

Optimizing Antihypertensive Medication Classification in Electronic Health Record-Based Data: Classification System Development and Methodological Comparison
por: McDonough, Caitrin W, et al.
Publicado: (2020)

Risk of Postdischarge Bleeding From Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Among US Black and White Adults
por: Heindl, Brittain, et al.
Publicado: (2022)

Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underserved
por: Gawronski, Brian E., et al.
Publicado: (2023)

Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar
por: Cho, Jung Rae, et al.
Publicado: (2014)

Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
por: Gragnano, Felice, et al.
Publicado: (2022)

A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertension
por: Coons, James C., et al.
Publicado: (2021)

Cox-sMBPLS: An Algorithm for Disease Survival Prediction and Multi-Omics Module Discovery Incorporating Cis-Regulatory Quantitative Effects
por: Vahabi, Nasim, et al.
Publicado: (2021)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Diet in Stroke: Beyond Antiplatelets and Statins
por: James, Joe
Publicado: (2019)

Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
por: Angiolillo, Dominick J., et al.
Publicado: (2021)

Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics
por: Sá, Ana Caroline C., et al.
Publicado: (2017)

Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study
por: Armstrong, Nicole D., et al.
Publicado: (2022)

Evaluation of race and ethnicity disparities in outcome studies of CYP2C19 genotype-guided antiplatelet therapy
por: Nguyen, Anh B., et al.
Publicado: (2022)

Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β‐Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil‐SR Trandolapril Study) Trials
por: Magvanjav, Oyunbileg, et al.
Publicado: (2017)

In response to “The Knowledge of Our Knowledge”: a reflection on McAndrews’ view of epistemology
por: Winterstein, James
Publicado: (2012)

Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
por: Brown, Joshua D., et al.
Publicado: (2019)

1362. Antibiotic Prescribing for Acute Otitis Media in Commercially Insured Pediatric Patients in the United States
por: Smolinski, Nicole, et al.
Publicado: (2020)

Triangulation of pharmacoepidemiology and laboratory science to tackle otic quinolone safety
por: Winterstein, Almut G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_37t78mlpecq2l9q2bhng38m3pn